会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • MEDICAMENT FOR THE TREATMENT OF VIRAL SKIN AND TUMOUR DISEASES
    • 用于治疗病毒性皮肤病和肿瘤病的药物
    • US20110009481A1
    • 2011-01-13
    • US12887250
    • 2010-09-21
    • Yunik ChangRobert LathropErwin BöhmIrene Gander-MeisterernstRegina GregerJohanna HolldackUlrich Moebius
    • Yunik ChangRobert LathropErwin BöhmIrene Gander-MeisterernstRegina GregerJohanna HolldackUlrich Moebius
    • A61K31/353A61P35/00A61P17/00
    • A61K9/0014A61K31/23A61K31/353A61K47/06A61K47/10A61K47/14Y10S514/934Y10S514/947Y10S514/967Y10S514/969A61K2300/00
    • The invention relates to a medicament containing a compound of general formula (I), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkinyl group, preferably a C11-C15 alkyl, alkylene or alkinyl group, particularly a C11-C13 alkyl, alkylene or alkinyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkinyl group, preferably a C1-C6 alkyl, alkylene or alkinyl group, in particular a C2-C4 alkyl, alkylene or alkinyl group, most preferably a C3 alkyl group, a —[CH2—(CH2)m-O]nH group with n=1 to 10, preferably n=1 to 5, to m=1 to 5, preferably m=1 to 3, a —CH2—[CH—(OH)]p[CH2—R3]- group, where R3=independently H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tumor diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses and a topically acting medicament formulation and the use thereof.
    • 本发明涉及含有通式(I)化合物的药物,其中R 1独立地为直链或支链的,饱和的,单或多不饱和的任选取代的C 11 -C 21烷基,亚烷基或炔基,优选C 11 -C 15烷基,亚烷基或炔基,特别是C 11 -C 13烷基,亚烷基或炔基,最优选C 13烷基,R 2独立地为直链或支链C 1 -C 8烷基,亚烷基或炔基,优选C1- C 1 -C 6烷基,亚烷基或炔基,特别是C 2 -C 4烷基,亚烷基或炔基,最优选C 3烷基, - n = 1-10的α-[CH 2 - (CH 2)m O] n H基,优选n = 1至5,m = 1至5,优选m = 1至3,-CH 2 - [CH-(OH)] p [CH 2 -R 3] - 基,其中R 3独立地为H或OH,p = 7,优选p = 1〜4,戊糖基或己糖基作为治疗活性剂,单独或与一种或几种其它药剂组合,作为tre的组合制剂 特别是由人乳头瘤病毒(HPV)和/或疱疹病毒和局部作用的药物制剂引起的病毒性皮肤病和/或肿瘤疾病的发生及其用途。
    • 3. 发明授权
    • Medicament for the treatment of viral skin and tumour diseases
    • 用于治疗病毒性皮肤和肿瘤疾病的药物
    • US07858662B2
    • 2010-12-28
    • US10495889
    • 2002-11-18
    • Yunik ChangRobert LathropErwin BöhmIrene Gander-MeisterernstRegina GregerJohanna HolldackUlrich Moebius
    • Yunik ChangRobert LathropErwin BöhmIrene Gander-MeisterernstRegina GregerJohanna HolldackUlrich Moebius
    • A61K31/20A61K31/12A61K31/35A61P15/00
    • A61K9/0014A61K31/23A61K31/353A61K47/06A61K47/10A61K47/14Y10S514/934Y10S514/947Y10S514/967Y10S514/969A61K2300/00
    • The invention relates to a medicament containing a compound of general formula (1), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkynyl group, preferably a C11-C15 alkyl, alkylene or alkynyl group, particularly a C11-C13 alkyl, alkylene or alkynyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkynyl group, preferably a C1-C6 alkyl, alkylene or alkynyl group, in particular a C2-C4 alkyl, alkylene or alkynyl group, most preferably a C3 alkyl group, a —[CH2—(CH2)m—O]nH group with n=1 to 10, preferably n=1 to 5, m=1 to 5, preferably m=1 to 3, a —CH2—[CH—(OH)]p[CH2—(R3)]— group, where R3=independent H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tumor diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses and a topically acting medicament formulation and the use thereof.
    • 本发明涉及含有通式(1)化合物的药物,其中R 1独立地为直链或支链的,饱和的,单或多不饱和的任选取代的C 11 -C 21烷基,亚烷基或炔基,优选C 11 -C 15烷基,亚烷基或炔基,特别是C 11 -C 13烷基,亚烷基或炔基,最优选C 13烷基,R 2独立地为直链或支链C 1 -C 8烷基,亚烷基或炔基, C 1 -C 6烷基,亚烷基或炔基,特别是C 2 -C 4烷基,亚烷基或炔基,最优选C 3烷基, - n = 1-10的α-[CH 2 - (CH 2)m -O] n H基团 n = 1至5,m = 1至5,优选m = 1至3,-CH 2 - [CH-(OH)] p [CH 2 - (R 3)] - 基,其中R 3 =独立的H或OH,p = 1至7,优选p = 1至4,戊糖基或己糖基,作为治疗活性剂,单独或与一种或几种其它药剂组合,作为tr的组合制剂 特别是由人乳头状瘤病毒(HPV)和/或疱疹病毒引起的病毒性皮肤疾病和/或肿瘤疾病,以及局部作用的药物制剂及其用途。